Dividends Calendar Earnings Calendar
NERV

NERV | Minerva Neurosciences Inc

Minerva Neurosciences Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 60.66M
  • Prev closed: 2.29
  • Open: 2.22
  • High: 2.31
  • Low: 2.15
  • 52 week low: 1.81
  • 52 week high: 15.22
  • Dividends:No Dividends

Next ER: November 1, 2021 



Top Stories (NERV)

    Company Profile

    Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of products to treat central nervous system (CNS) diseases. Minerva's portfolio of compounds includes: Roluperidone (MIN-101) in Phase 3 clinical  development for schizophrenia; a potential royalty stream from Seltorexant (MIN-202 or JNJ 42847922), in clinical development for insomnia and major depressive disorder (MDD); and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV."

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 2, 2021-0.25 / -0.174- / 574K
    May 12, 2021-0.21 / 0.332- / 24M
    March 8, 2021-0.17 / -0.1909- / -
    November 2, 2020-0.19 / -0.2307- / -
    August 3, 20200.73 / -0.2941.18M / -Beat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Oct 8, 2021 1.430 1.450
    1.460
    1.410
    241.12K 0.70%
    Oct 7, 2021 1.420 1.400
    1.460
    1.380
    246.88K 2.16%
    Oct 6, 2021 1.390 1.450
    1.460
    1.370
    567.59K -4.14%
    Oct 5, 2021 1.450 1.520
    1.530
    1.415
    688.37K -3.97%
    Oct 4, 2021 1.510 1.580
    1.581
    1.450
    955.27K -4.43%
    Oct 1, 2021 1.580 1.770
    1.799
    1.530
    2.12M -9.2%
    Sep 30, 2021 1.740 1.820
    1.880
    1.656
    1.74M -1.69%
    Sep 29, 2021 1.770 1.870
    1.915
    1.760
    530.37K -4.32%
    Sep 28, 2021 1.850 2.010
    2.010
    1.820
    758.34K -8.42%
    Sep 27, 2021 2.020 2.030
    2.100
    1.960
    1.10M -0.98%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:11

    News

    News for (NERV)

    This company doesn't provide a dividend.


    Talk about Minerva Neurosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 1, 2021 (Same day)

    l pypl mdlz swks sedg clr mos jazz rig pcg fe wmb 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Internet of Money
    Buy on Amazon

    While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.